Pharmaceutical companies have a new worry in ensuring communications about their products do not run afoul of advertising rules in the European Union: posts on LinkedIn.
Dozens of complaints against companies have been submitted to the Prescription Medicines Code of Practice Authority (PMCPA), the self-regulatory body enforcing UK’s advertising
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?